Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
J Am Soc Nephrol
2023 Mar 01;343:451-466. doi: 10.1681/ASN.0000000000000054.
Show Gene links
Show Anatomy links
Genetic and Physiological Effects of Insulin-Like Growth Factor-1 (IGF-1) on Human Urate Homeostasis.
Mandal AK
,
Leask MP
,
Sumpter NA
,
Choi HK
,
Merriman TR
,
Mount DB
.
Abstract
SIGNIFICANCE STATEMENT: Hyperinsulinemia induces hyperuricemia by activating net renal urate reabsorption in the renal proximal tubule. The basolateral reabsorptive urate transporter GLUT9a appears to be the dominant target for insulin. By contrast, IGF-1 infusion reduces serum urate (SU), through mechanisms unknown. Genetic variants of IGF1R associated with reduced SU have increased IGF-1R expression and interact with genes encoding the GLUT9 and ABCG2 urate transporters, in a sex-specific fashion, which controls the SU level. Activation of IGF-1/IGF-1R signaling in Xenopus oocytes modestly activates GLUT9a and inhibits insulin's stimulatory effect on the transporter, which also activates multiple secretory urate transporters-ABCG2, ABCC4, OAT1, and OAT3. The results collectively suggest that IGF-1 reduces SU by activating secretory urate transporters and inhibiting insulin's action on GLUT9a.
BACKGROUND: Metabolic syndrome and hyperinsulinemia are associated with hyperuricemia. Insulin infusion in healthy volunteers elevates serum urate (SU) by activating net urate reabsorption in the renal proximal tubule, whereas IGF-1 infusion reduces SU by mechanisms unknown. Variation within the IGF1R gene also affects SU levels.
METHODS: Colocalization analyses of a SU genome-wide association studies signal at IGF1R and expression quantitative trait loci signals in cis using COLOC2, RT-PCR, Western blotting, and urate transport assays in transfected HEK 293T cells and in Xenopus laevis oocytes.
RESULTS: Genetic association at IGF1R with SU is stronger in women and is mediated by control of IGF1R expression. Inheritance of the urate-lowering homozygous genotype at the SLC2A9 locus is associated with a differential effect of IGF1R genotype between men and women. IGF-1, through IGF-1R, stimulated urate uptake in human renal proximal tubule epithelial cells and transfected HEK 293T cells, through activation of IRS1, PI3/Akt, MEK/ERK, and p38MAPK; urate uptake was inhibited in the presence of uricosuric drugs, specific inhibitors of protein tyrosine kinase, PI3 kinase (PI3K), ERK, and p38MAPK. In X. laevis oocytes expressing ten individual urate transporters, IGF-1 through endogenous IGF-1R stimulated urate transport mediated by GLUT9, OAT1, OAT3, ABCG2, and ABCC4 and inhibited insulin's stimulatory action on GLUT9a and OAT3. IGF-1 significantly activated Akt and ERK. Specific inhibitors of PI3K, ERK, and PKC significantly affected IGF-1 stimulation of urate transport in oocytes.
CONCLUSIONS: The combined results of infusion, genetics, and transport experiments suggest that IGF-1 reduces SU by activating urate secretory transporters and inhibiting insulin's action.
Adams,
Structure and function of the type 1 insulin-like growth factor receptor.
2000, Pubmed
Adams,
Structure and function of the type 1 insulin-like growth factor receptor.
2000,
Pubmed
Allard,
IGF-Binding Proteins: Why Do They Exist and Why Are There So Many?
2018,
Pubmed
Anzai,
Plasma urate level is directly regulated by a voltage-driven urate efflux transporter URATv1 (SLC2A9) in humans.
2008,
Pubmed
,
Xenbase
Augustin,
Identification and characterization of human glucose transporter-like protein-9 (GLUT9): alternative splicing alters trafficking.
2004,
Pubmed
,
Xenbase
Barros,
Activation of protein kinase Czeta increases OAT1 (SLC22A6)- and OAT3 (SLC22A8)-mediated transport.
2009,
Pubmed
Bhatnagar,
Analysis of ABCG2 and other urate transporters in uric acid homeostasis in chronic kidney disease: potential role of remote sensing and signaling.
2016,
Pubmed
Bibert,
Mouse GLUT9: evidences for a urate uniporter.
2009,
Pubmed
,
Xenbase
Boocock,
Genomic dissection of 43 serum urate-associated loci provides multiple insights into molecular mechanisms of urate control.
2020,
Pubmed
Caetano-Pinto,
Cetuximab Prevents Methotrexate-Induced Cytotoxicity in Vitro through Epidermal Growth Factor Dependent Regulation of Renal Drug Transporters.
2017,
Pubmed
Canzian,
Polymorphisms of genes coding for insulin-like growth factor 1 and its major binding proteins, circulating levels of IGF-I and IGFBP-3 and breast cancer risk: results from the EPIC study.
2006,
Pubmed
Caulfield,
SLC2A9 is a high-capacity urate transporter in humans.
2008,
Pubmed
,
Xenbase
Cicirelli,
Microinjection of a protein-tyrosine-phosphatase inhibits insulin action in Xenopus oocytes.
1990,
Pubmed
,
Xenbase
Cicirelli,
Insulin and progesterone activate a common synthetic ribosomal protein S6 peptide kinase in Xenopus oocytes.
1988,
Pubmed
,
Xenbase
DeBosch,
Early-onset metabolic syndrome in mice lacking the intestinal uric acid transporter SLC2A9.
2014,
Pubmed
Dinour,
Homozygous SLC2A9 mutations cause severe renal hypouricemia.
2010,
Pubmed
,
Xenbase
Döring,
SLC2A9 influences uric acid concentrations with pronounced sex-specific effects.
2008,
Pubmed
Enomoto,
Molecular identification of a renal urate anion exchanger that regulates blood urate levels.
2002,
Pubmed
,
Xenbase
Fetsch,
Localization of the ABCG2 mitoxantrone resistance-associated protein in normal tissues.
2006,
Pubmed
Fujinaka,
Expression and localization of insulin-like growth factor binding proteins in normal and proteinuric kidney glomeruli.
2010,
Pubmed
Giambartolomei,
Bayesian test for colocalisation between pairs of genetic association studies using summary statistics.
2014,
Pubmed
Grigorescu,
Insulin and IGF-1 signaling in oocyte maturation.
1994,
Pubmed
,
Xenbase
Guler,
Effects of recombinant insulin-like growth factor I on insulin secretion and renal function in normal human subjects.
1989,
Pubmed
Hainaut,
Insulin and insulin-like-growth-factor-I (IGF-I) receptors in Xenopus laevis oocytes. Comparison with insulin receptors from liver and muscle.
1991,
Pubmed
,
Xenbase
Hanai,
Involvement of p44/p42 MAP kinase in insulin-like growth factor-I-induced alkaline phosphatase activity in osteoblast-like-MC3T3-E1 cells.
2006,
Pubmed
Hernández-Sánchez,
The role of the tyrosine kinase domain of the insulin-like growth factor-I receptor in intracellular signaling, cellular proliferation, and tumorigenesis.
1995,
Pubmed
Higashino,
Dysfunctional missense variant of OAT10/SLC22A13 decreases gout risk and serum uric acid levels.
2020,
Pubmed
Hoque,
The ABCG2 Q141K hyperuricemia and gout associated variant illuminates the physiology of human urate excretion.
2020,
Pubmed
Hosomi,
Extra-renal elimination of uric acid via intestinal efflux transporter BCRP/ABCG2.
2012,
Pubmed
Huls,
The breast cancer resistance protein transporter ABCG2 is expressed in the human kidney proximal tubule apical membrane.
2008,
Pubmed
Ichida,
Decreased extra-renal urate excretion is a common cause of hyperuricemia.
2012,
Pubmed
Iharada,
Type 1 sodium-dependent phosphate transporter (SLC17A1 Protein) is a Cl(-)-dependent urate exporter.
2010,
Pubmed
Janicot,
The insulin-like growth factor 1 (IGF-1) receptor is responsible for mediating the effects of insulin, IGF-1, and IGF-2 in Xenopus laevis oocytes.
1991,
Pubmed
,
Xenbase
Jutabha,
Identification of a novel voltage-driven organic anion transporter present at apical membrane of renal proximal tubule.
2003,
Pubmed
,
Xenbase
Kimura,
Expression of SLC2A9 isoforms in the kidney and their localization in polarized epithelial cells.
2014,
Pubmed
Köttgen,
Genome-wide association analyses identify 18 new loci associated with serum urate concentrations.
2013,
Pubmed
LeRoith,
Molecular and cellular aspects of the insulin-like growth factor I receptor.
1995,
Pubmed
Liman,
Subunit stoichiometry of a mammalian K+ channel determined by construction of multimeric cDNAs.
1992,
Pubmed
,
Xenbase
Liu,
Insulin-like growth factor I is essential for postnatal growth in response to growth hormone.
1999,
Pubmed
Liu,
Association Between Uric Acid and Insulin-Like Growth Factor-1 in Type 2 Diabetes Mellitus.
2021,
Pubmed
Major,
An update on the genetics of hyperuricaemia and gout.
2018,
Pubmed
Mandal,
Uricosuric targets of tranilast.
2017,
Pubmed
,
Xenbase
Mandal,
The molecular physiology of uric acid homeostasis.
2015,
Pubmed
Mandal,
Interaction Between ITM2B and GLUT9 Links Urate Transport to Neurodegenerative Disorders.
2019,
Pubmed
,
Xenbase
Mandal,
Genetic and Physiological Effects of Insulin on Human Urate Homeostasis.
2021,
Pubmed
,
Xenbase
Mannino,
The polymorphism rs35767 at IGF1 locus is associated with serum urate levels.
2018,
Pubmed
Matsuo,
Identification of ABCG2 dysfunction as a major factor contributing to gout.
2011,
Pubmed
Muscelli,
Effect of insulin on renal sodium and uric acid handling in essential hypertension.
1996,
Pubmed
Nagao,
Distinct signaling by insulin and IGF-1 receptors and their extra- and intracellular domains.
2021,
Pubmed
Nissley,
Insulin-like growth factor receptors.
1985,
Pubmed
O'Keefe,
Enhanced insulin action on glucose transport and insulin signaling in 7-day unweighted rat soleus muscle.
2004,
Pubmed
Oh,
The insulin-like growth factor system in chronic kidney disease: Pathophysiology and therapeutic opportunities.
2012,
Pubmed
Orosz,
Growth, immortalization, and differentiation potential of normal adult human proximal tubule cells.
2004,
Pubmed
Palles,
Identification of genetic variants that influence circulating IGF1 levels: a targeted search strategy.
2008,
Pubmed
Phipps-Green,
Twenty-eight loci that influence serum urate levels: analysis of association with gout.
2016,
Pubmed
Quiñones Galvan,
Effect of insulin on uric acid excretion in humans.
1995,
Pubmed
Rechler,
The nature and regulation of the receptors for insulin-like growth factors.
1985,
Pubmed
Rubin,
Stimulation of tyrosine-specific phosphorylation in vitro by insulin-like growth factor I.
NULL,
Pubmed
Saito,
Pathophysiological regulation of renal SLC22A organic ion transporters in acute kidney injury: pharmacological and toxicological implications.
2010,
Pubmed
Scavo,
Genes encoding receptors for insulin and insulin-like growth factor I are expressed in Xenopus oocytes and embryos.
1991,
Pubmed
,
Xenbase
Sesti,
Low circulating insulin-like growth factor-1 levels are associated with high serum uric acid in nondiabetic adult subjects.
2014,
Pubmed
Shepherd,
Phosphoinositide 3-kinase: the key switch mechanism in insulin signalling.
1998,
Pubmed
Soodvilai,
Involvement of tyrosine kinase and PI3K in the regulation of OAT3-mediated estrone sulfate transport in isolated rabbit renal proximal tubules.
2005,
Pubmed
Sweet,
Organic anion transporter 3 (Slc22a8) is a dicarboxylate exchanger indirectly coupled to the Na+ gradient.
2003,
Pubmed
,
Xenbase
Tanner,
Population-Specific Resequencing Associates the ATP-Binding Cassette Subfamily C Member 4 Gene With Gout in New Zealand Māori and Pacific Men.
2017,
Pubmed
,
Xenbase
Ter Maaten,
Renal handling of urate and sodium during acute physiological hyperinsulinaemia in healthy subjects.
1997,
Pubmed
Tin,
Target genes, variants, tissues and transcriptional pathways influencing human serum urate levels.
2019,
Pubmed
Ullrich,
Human insulin receptor and its relationship to the tyrosine kinase family of oncogenes.
NULL,
Pubmed
Ullrich,
Insulin-like growth factor I receptor primary structure: comparison with insulin receptor suggests structural determinants that define functional specificity.
1986,
Pubmed
Vitart,
SLC2A9 is a newly identified urate transporter influencing serum urate concentration, urate excretion and gout.
2008,
Pubmed
,
Xenbase
Wang,
Insulin-like growth factor-1 receptor-mediated inhibition of A-type K(+) current induces sensory neuronal hyperexcitability through the phosphatidylinositol 3-kinase and extracellular signal-regulated kinase 1/2 pathways, independently of Akt.
2014,
Pubmed
Werner,
Similarities and differences between insulin and IGF-I: structures, receptors, and signalling pathways.
2008,
Pubmed
Witkowska,
Human SLC2A9a and SLC2A9b isoforms mediate electrogenic transport of urate with different characteristics in the presence of hexoses.
2012,
Pubmed
,
Xenbase
Woodward,
Identification of a urate transporter, ABCG2, with a common functional polymorphism causing gout.
2009,
Pubmed
,
Xenbase
Yakar,
Insulin-like growth factor 1 physiology: lessons from mouse models.
2012,
Pubmed
Zhang,
Regulation of organic anion transporters: Role in physiology, pathophysiology, and drug elimination.
2021,
Pubmed
Zhang,
Insulin-like growth factor 1 modulates the phosphorylation, expression, and activity of organic anion transporter 3 through protein kinase A signaling pathway.
2020,
Pubmed
Zhu,
Molecular cloning and characterization of Xenopus insulin-like growth factor-1 receptor: its role in mediating insulin-induced Xenopus oocyte maturation and expression during embryogenesis.
1998,
Pubmed
,
Xenbase
